FDA Changes 2017 - Web Conference by Compliance4all on Device Changes, FDA Changes, and the 510(k)

Overview:
The majority of medical devices are cleared for marketing in the U.S. by the FDA under the 510(k) process. The FDA holds companies responsible for filing new 510(k)s when one change is major enough to impact safety / effectiveness, or when a series of lesser changes finally reach the "tipping point".
Areas Covered in the Session:
U.S. FDA device clearance / approval
FDA's and EU's emphasis
Product changes and filing a new 510(k) - who's responsible
Tracking and evaluating changes - the "tipping point"
Who Will Benefit:
Senior management, project leaders, internal / external consultants
Regulatory affairs
Quality systems personnel / QAE
R&D and engineering staff
Speaker Profile:
John E Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link : http://www.compliance4all.com/control/w_product/~p...
Twitter Follow us ? https://twitter.com/compliance4all
Facebook Like us ? https://www.facebook.com/Compliance4all
LinkedIn Like us ? https://www.linkedin.com/company/compliance4all